← Leaderboards
Connie L Davis
University Of Washington
$25,483
Attributed
$25,483
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$25,483 · 3
By mechanism
M01$25,483 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Kris Kowdley$16,222,064
- Debbie S Gipson$9,175,721
- Kenneth E. Thummel$18,445,737
- Michael Scott Mulligan$3,425,510
- Robert L Carithers$2,068,652
Others in their field
Top investigators on “Hemodialysis”
- Gerald J Beck · Cleveland Clinic Foundation$25,607,449
- Laura M Dember · Univ Of North Carolina Chapel Hill$15,973,453
- Sanjay Misra · Mayo Clinic Rochester$12,663,075
- Myles S Wolf · Duke University$11,798,574
- Stuart Johnston Knechtle · University Of Wisconsin Madison$11,789,092
- Alfred K. Cheung · University Of Utah$11,215,629
Research focus
HemodialysisLiver DisorderMicroorganism Disease ChemotherapyHepatitis CHuman SubjectHuman Therapy EvaluationHepatitis C VirusLiver Disorder ChemotherapySpecies DifferenceVirus Infection MechanismAntiviral AgentsInterferon AlphaChronic Disease /DisorderGenotypeDrug Administration Rate /DurationClinical ResearchDrug Screening /EvaluationDoseDonor, OrganKidney TransplantationLabelGrantFundingAntibodies
Grant awards (6)
MYCOPHENOLATE MOFETIL AND ANTI-HLA ANTIBODY LEVELS IN CADAVERIC RENAL TRANSPLANT$20,400
M01 · FY2007 · RR · contact PI
THE HIGHLY SENSITIZED PATIENT: EFFECTS OF RITUXIMAB$1,219
M01 · FY2007 · RR · contact PI
INTERFERON IN DIALYSIS PTS W/ HEPATITIS C VIRUS INFECTION$0
M01 · FY2002 · RR
INTERFERON IN DIALYSIS PTS W/ HEPATITIS C VIRUS INFECTION$0
M01 · FY2001 · RR
INTERFERON THERAPY FOR DIALYSIS PATIENTS W/ CHRONIC HEPATITIS C VIRUS INFECTION$3,864
M01 · FY2000 · RR
INTERFERON IN DIALYSIS PTS W/ HEPATITIS C VIRUS INFECTION$0
M01 · FY2000 · RR